Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

KV4.2 Inhibitors

KV4.2 inhibitors constitute a group of compounds that reduce the activity of KV4.2 potassium channels, which are integral to the regulation of membrane excitability in both neuronal and cardiac cells. These channels are responsible for the transient outward potassium current, which helps to repolarize the membrane following an action potential. Inhibitors of KV4.2 channels can act through a variety of mechanisms, such as direct pore blockade, altering channel gating kinetics, or disrupting channel protein expression and trafficking to the membrane. Direct inhibitors typically bind within the pore region of the channel or at allosteric sites that influence the channel's open state, thereby preventing potassium ions from passing through the channel and contributing to the repolarization phase of the action potential.

Beyond direct blockade, certain KV4.2 inhibitors may function indirectly by modulating intracellular signaling pathways that affect channel activity. For example, they might inhibit kinase activity that normally phosphorylates and activates the channel, or they could activate phosphatases that dephosphorylate and inactivate the channel. Some inhibitors alter the lipid composition of the cell membrane, which can affect the channel's biophysical properties and its interactions with regulatory proteins. Others might influence the expression levels of the channel or its auxiliary subunits, thereby impacting the density of functional channels on the cell surface.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

4-Aminopyridine

504-24-5sc-202421
sc-202421B
sc-202421A
25 g
1 kg
100 g
$38.00
$1155.00
$122.00
3
(2)

Blocks voltage-gated potassium channels including KV4.2 by binding to the open channel and preventing potassium efflux.

Tetraethylammonium chloride

56-34-8sc-202834
25 g
$45.00
2
(1)

A classic potassium channel blocker that can inhibit a broad spectrum of potassium channels, including KV4.2, by occluding the pore.

Fluoxetine

54910-89-3sc-279166
500 mg
$318.00
9
(1)

Commonly known as an SSRI, has been reported to block neuronal potassium channels and could affect KV4.2.